Samumed, LLC is engaged in small molecule drug development using assays and screens for the treatment of oncology and degenerative diseases. Its product includes SM04690, a small molecule inhibitor of the Wnt pathway that is administered as an intra-articular injection for treatment of osteoarthritis of the knee; and SM07883, a small-molecule designed to reduce disease pathology. The company was known as Wintherix & Epitherix, LLC. Samumed, LLC was founded in 2007 and is based in San Diego, California.
Samumed, LLC is engaged in small molecule drug development using assays and screens for the treatment of oncology and degenerative diseases. Its product includes SM04690, a small molecule inhibitor of the Wnt pathway that is administered as an intra-articular injection for treatment of osteoarthritis of the knee; and SM07883, a small-molecule designed to reduce disease pathology. The company was known as Wintherix & Epitherix, LLC. Samumed, LLC was founded in 2007 and is based in San Diego, California.